BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25979380)

  • 1. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
    Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
    Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1, Jagged1, and HES5 are abundantly expressed in osteoarthritis.
    Karlsson C; Brantsing C; Egell S; Lindahl A
    Cells Tissues Organs; 2008; 188(3):287-98. PubMed ID: 18354251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-Hes1 pathway contributes to the cochlear prosensory formation potentially through the transcriptional down-regulation of p27Kip1.
    Murata J; Ohtsuka T; Tokunaga A; Nishiike S; Inohara H; Okano H; Kageyama R
    J Neurosci Res; 2009 Dec; 87(16):3521-34. PubMed ID: 19598246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
    Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
    Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Notch signaling in human breast cancer].
    Dong XB; Ji CY; Ma DX; Ma R; Zang SL; Yu HQ; Guo DM
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):425-8. PubMed ID: 17974275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
    Katoh M; Katoh M
    Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression changes of Notch-related genes during the differentiation of human mesenchymal stem cells into neurons].
    Xing Y; Bai RY; Yan WH; Han XF; Duan P; Xu Y; Fan ZG
    Sheng Li Xue Bao; 2007 Jun; 59(3):267-72. PubMed ID: 17579779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Jagged-1 inhibits neointima formation by attenuating Notch-Herp2 signaling.
    Caolo V; Schulten HM; Zhuang ZW; Murakami M; Wagenaar A; Verbruggen S; Molin DG; Post MJ
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1059-65. PubMed ID: 21330605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.
    Reedijk M; Odorcic S; Chang L; Zhang H; Miller N; McCready DR; Lockwood G; Egan SE
    Cancer Res; 2005 Sep; 65(18):8530-7. PubMed ID: 16166334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated expression of Notch1 and Jagged1 in human colon adenocarcinoma.
    Gao J; Liu J; Fan D; Xu H; Xiong Y; Wang Y; Xu W; Wang Y; Cheng Y; Zheng G
    Pathol Biol (Paris); 2011 Dec; 59(6):298-302. PubMed ID: 21145176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Notch signaling in human tongue carcinoma.
    Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
    J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Notch1, Jagged1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma.
    Wang M; Xue L; Cao Q; Lin Y; Ding Y; Yang P; Che L
    Neoplasma; 2009; 56(6):533-41. PubMed ID: 19728763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of Notch1 signaling was increased in parallel with neurogenesis in rat hippocampus after chronic fluoxetine administration.
    Sui Y; Zhang Z; Guo Y; Sun Y; Zhang X; Xie C; Li Y; Xi G
    Biol Pharm Bull; 2009 Oct; 32(10):1776-82. PubMed ID: 19801843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
    Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
    Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.